Pharmaceutical Development as Case Study with High-Risk, High-Return Project Management

Koji Iwasaki
Additional contact information
Koji Iwasaki: Pharmaceutical Development Division, Takeda Pharmaceutical Company Limited, Japan

Chapter 19 in Japanese Project Management:KPM — Innovation, Development and Improvement, 2008, pp 281-293 from World Scientific Publishing Co. Pte. Ltd.

Abstract: AbstractThe following sections are included:IntroductionPharmaceutical Development as a High-Risk and High-Return Project ManagementProgram Management and Program Architecture of Clinical TrialsBasic structureModularityInterface and integrationTotal functionDevelopment of basic specification and modular projectIntegration of clinical trial processesBasic operabilityProgram road mapGrand designThe Future of Clinical DevelopmentOrganizational correspondence to modularity and globalizationCreation of program value and the added value of clinical development for the enterpriseReferences

Keywords: Corporate Reforms; Business Innovation; Technology Development; Japanese Project Management; Strategy-Linked Implementation; Complexity; Value Creation; Systems; Modeling; Partnership (search for similar items in EconPapers)
Date: 2008
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.worldscientific.com/doi/pdf/10.1142/9789812778741_0019 (application/pdf)
https://www.worldscientific.com/doi/abs/10.1142/9789812778741_0019 (text/html)
Ebook Access is available upon purchase.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wsi:wschap:9789812778741_0019

Ordering information: This item can be ordered from

Access Statistics for this chapter

More chapters in World Scientific Book Chapters from World Scientific Publishing Co. Pte. Ltd.
Bibliographic data for series maintained by Tai Tone Lim ().